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In Brief
Cytomegalovirus (CMV) is shed from the
salivary gland and other mucosal tissues,
yet the CD8 response at these sites is
poorly understood. Smith et al. show that
MCMV-specific tissue-resident CD8
populations are supported by
continuous, low-level recruitment of
circulating CD8s that become TRM in an
antigen-dependent manner.
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Cytomegalovirus (CMV) is a herpesvirus that per-
sists for life and maintains extremely large numbers
of T cells with select specificities in circulation. How-
ever, it is unknown how viral persistence impacts
T cell populations in mucosal sites. We found that
many murine (M)CMV-specific CD8s in mucosal
tissues became resident memory T cells (TRM).
These cells adopted an intraepithelial localization
in the salivary gland that correlated with, but did
not depend on, expression of the integrin CD103.
MCMV-specific TRM cells formed early after infec-
tion, and spleen-localized cells had reduced capac-
ities to become TRM at late times. Surprisingly,
however, small numbers of new TRM cells were
formed from the circulating pool throughout infec-
tion, favoring populations maintained at high levels
in the blood and shifting the immunodominance
within the TRM populations over time. These data
show that mucosal TRM populations can be dynami-
cally maintained by a persistent infection.
INTRODUCTION
Cytomegalovirus (CMV) is a b-herpesvirus that infects the major-
ity of people in the world and establishes an asymptomatic la-
tency, punctuated by periodic reactivation (Crough and Khanna,
2009). Controlling these reactivation events requires constant
immune surveillance (Polic et al., 1998; Simon et al., 2006), which
induces the accumulation of virus-specific T cells in a unique
process called ‘‘memory inflation’’ (Holtappels et al., 2000; Kar-
rer et al., 2003; Komatsu et al., 2003; Munks et al., 2006). This
has led to great interest in using CMV as a vaccine vector, with
pre-clinical success in a non-human primate model of HIV infec-
tion (Hansen et al., 2009, 2011, 2013). Like most herpesviruses,
CMV displays strict species specificity. Thus, we use murine
CMV (MCMV), a natural mouse pathogen and the homolog of hu-
man (H)CMV. The T cells induced by both viruses are broadly
similar in phenotype, function, and genetic signature (Crough
and Khanna, 2009; Krmpotic et al., 2003; Quinn et al., 2015;
Snyder et al., 2011). Using the MCMV model, we found that
most of the ‘‘inflationary’’ CD8+ T cells (those that accumulateCell Repover time) are confined to the circulation after systemic MCMV
infection (Smith et al., 2014). The major exception to this finding
was the salivary gland, where MCMV and HCMV both persist
and establish latency (Crough and Khanna, 2009; Krmpotic
et al., 2003; Polic et al., 1998). It is unknown how CMV-specific
T cells develop in this or other mucosal tissues.
It has become clear in recent years that many pathogen-spe-
cific T cells within the skin, brain, and mucosal tissues, including
the salivary gland, are not in equilibrium with those circulating
through the blood and lymphoid organs. These populations
have been called tissue-resident memory T cells (TRM), and
they are thought to form early after infection, persisting in these
tissues independently of circulation (reviewed in Schenkel and
Masopust, 2014). In the small intestine, vagina, skin, and lung,
pathogen-specific TRM cells localize near or within the epithe-
lial layer, which is thought to enable TRM cells to be ‘‘first-
responders’’: cells that do not require recruitment to rapidly
respond to reinfection (Ariotti et al., 2014; Gebhardt et al.,
2009; Mackay et al., 2012; Schenkel et al., 2013; Sheridan
et al., 2014; Wu et al., 2014; Zhu et al., 2013). For these reasons,
establishing TRM in large numbers may be critically important in
maintaining immune surveillance in these organs and is a major
concern for vaccine design.
Several lines of evidence suggest that TRM cells form indepen-
dently of local antigen (Casey et al., 2012; Hofmann and Pircher,
2011; Mackay et al., 2012; Wakim et al., 2010). In fact, work with
lymphocytic choriomeningitis (LCMV) clone 13, which induces a
chronic infection that promotes T cell dysfunction, suggested
that antigen may inhibit mucosal TRM populations (Casey et al.,
2012). Both MCMV and HCMV undergo prolonged replication
in the salivary gland and persist for life in many sites in the
body. However, unlike many persistent viruses, neither MCMV
nor HCMV promotes T cell dysfunction. The persistence of low
levels of antigen during CMV infection, along with the CMV-
driven accumulation of functional CD8+ T cells, raise the possi-
bility that the dynamics of T cell maintenance in the mucosa do
not reflect that of cleared infections or chronic infections that
drive exhaustion.
We found thatmanyMCMV-specificCD8+ T cells in the salivary
gland and other mucosal sites in the body developed a TRM
phenotype shortly after infection. Remarkably, our data suggest
that persistent antigen stimulation during viral latency promotes
the continuous, low-level recruitment of circulating inflationary
MCMV-specific T cells to the TRM population in the salivary gland,
which resulted in a slow shift in the immunodominance of theorts 13, 1137–1148, November 10, 2015 ª2015 The Authors 1137
Figure 1. MCMV-Specific CD8s Become
TRM in the Salivary Gland andOtherMucosal
Sites
(A) OT-Is in congenic B6 mice >12 weeks after
infection with MCMV-OVA. (Top row) FACS plots
of congenic OT-Is labeled with i.v. injected, fluo-
rochrome-labeled anti-CD8a antibody to identify
blood and tissue localized T cells and surface
stained with anti-CD8b in the indicated organs are
shown. (Bottom row) CD103 andCD69 expression
on OT-Is in the i.v. unlabeled fraction of indicated
organs (see also Figure S1) is shown. Data are
representative of two independent experiments
(n = 7).
(B) Immunofluorescent staining of OT-Is in the
salivary gland >12 weeks postinfection. Shown is
an OT-I (identified by CD45.2; green) expressing
CD103 (white) co-localized with the epithelium
(identified by E-cadherin; red). DAPI staining of the
nucleus is shown in blue. Individual images and
overlays are in Figure S2.
(C) FACS plot of CD103 and CD69 on M38-spe-
cific T cells in i.v. unlabeled fraction of salivary
gland >12 weeks post-wild-type MCMV infection.
(D and E) Mice were treated with BrdU in drinking
water for the first 9 weeks of MCMV infection and
then sacrificed 15weeks after the end of the pulse.
The frequency of BrdU-labeled cells among M38-
specific T cells in the indicated organ (D) and
among CD103 or CD103+ M38-specific cells in
the salivary gland (E) after the 15-week chase
period is shown. Data are representative of two
independent experiments.MCMV-specific TRM cells over time. These data suggest that
mucosal TRM populations driven by persistent infections can be
dynamically maintained.
RESULTS
MCMV-Specific TRMCD8sArePresent in LargeNumbers
in the Salivary Gland
MCMV is a systemic, persistent pathogen that induces the accu-
mulation of virus-specific CD8 T cells. We showed previously
that, after an i.p. infection, the vast majority of MCMV-specific
CD8s stimulated by viral antigen were in the blood or associated
with the vasculature during the latent stage of infection (Smith
et al., 2014). To investigate MCMV-specific CD8s in mucosal1138 Cell Reports 13, 1137–1148, November 10, 2015 ª2015 The Authorstissues, we used an MCMV virus ex-
pressing ovalbumin (MCMV-OVA) and
OT-Is. Naive mice were seeded with
small numbers of naive congenic OT-Is
and infected withMCMV-OVA 1 day later.
This protocol induces robust inflation of
OT-Is (Turula et al., 2013), which were
largely exposed to an i.v.-injected anti-
body, suggesting a vascular localiza-
tion (Figure 1A). When blood-localized
CD8s were excluded, the salivary gland
harbored the most OT-Is of the organs
studied (Figure S1A). Expression ofCD103 and CD69, the markers of TRM cells, was most pro-
nounced on T cells within the salivary gland and the intraepithe-
lial lymphocyte fraction of the small intestine (si-IEL) (Figures 1A
and S1B). Moreover, cells in both of these sites tended to ex-
press low or intermediate amounts of the IL-7Ra (CD127) and
lacked KLRG1 (Figures S1C and S1D), consistent with the TRM
phenotype (Mackay et al., 2013; Sheridan et al., 2014). Impor-
tantly, many of the MCMV-driven OT-Is in the salivary gland
were IELs located within the acinii and ducts (Figures 1B and
S2). Endogenous CD8 T cells specific for MCMV epitopes also
upregulated TRM markers in the salivary gland (M38-specific
T cells shown in Figure 1C). To test whether these T cells were
lodged in the salivary gland, we performed a BrdU pulse during
the first 9 weeks of infection, followed by a prolonged chase
Figure 2. Localization and Maintenance of
MCMV-Specific CD8s in the Salivary Gland
Do Not Depend on CD103 Expression
B6 mice were seeded with wild-type or CD103/
OT-Is and challenged with MCMV-OVA.
(A) Localization of OT-Is in the salivary gland was
examined histologically by immunofluorescent
staining >12 weeks after infection. (Left) Distance
from the nearest epithelial surface of wild-type
OT-Is in the salivary gland that did (n = 121 cells) or
did not (n = 87 cells) express CD103 is shown.
(Right) Distance of OT-Is from the nearest epithe-
lial surface for wild-type OT-Is (whole population;
n = 223 cells) compared to CD103/OT-Is (n = 83
cells) is shown.
(B) CD103/ OT-Is (identified by CD45.2; green)
embedded in the epithelium (identified by E-cad-
herin; red). CD103 is shown in white, and DAPI is
shown in blue (see also Figure S3). Data are
representative of two to four tissue sections per
mouse from four mice containing wild-type OT-Is
and three mice containing CD103/ OT-Is.
(C–F) Wild-type and CD103/ OT-Is were mixed
and co-transferred before MCMV-OVA challenge.
Cohorts were sacrificed at different times post-
infection. (C) Ratio of CD103/ to WT OT-Is in
the spleen, salivary gland, and intestinal IEL
normalized to ratio in the blood within the same
mouse at 1 week postinfection is shown. (D) Ratio
of CD103/ to WT OT-Is in each organ over time
normalized within an experiment to the average
ratio in the blood at week 1 is shown. Frequency
of indicated phenotype of WT OT-Is (E) and
CD103/ OT-Is (F) in the salivary gland over time
is shown. See also Figure S4. Results are com-
bined from two independent experiments (n = 7).
(G and H) Wild-type and CD103/ OT-Is were
mixed and co-transferred before MCMV-OVA
infection. One week postinfection, WT and
CD103/ OT-Is were sorted from the spleen and
equal numbers mixed and transferred into naive
congenic recipients. (G) CD103 and CD69 on
OT-Is in the salivary gland 2 weeks after transfer
are shown. (H) Ratio of CD103/WT OT-Is in
the indicated organ of naive recipients at 2 and
5 weeks posttransfer is shown. Results are com-
bined from two independent experiments (n = 8).
Error bars represent the SEM. Statistical signifi-
cance was measured by paired (A and C) or
unpaired (D and G) Student’s t tests (*p < 0.05;
**p < 0.01; ***p < 0.001).period. The ongoing antigen-driven memory inflation causes a
loss of BrdU-positive inflationary T cells in circulation (Smith
et al., 2014). However, inflationary T cells in the salivary gland re-
tained BrdU at a much-greater frequency than cells extracted
from the spleen, lungs, and liver (Figure 1D). The retention of
the BrdU label was especially prominent in the CD103+ subset
of MCMV-specific cells in the salivary gland (Figure 1E). Thus,
salivary-gland-localized T cells are not in equilibrium with the
circulating populations. Together, these data show that MCMV
infection promotes TRM cells in multiple mucosal tissues and
that TRM cells are lodged in the salivary gland, where they
develop an IEL localization.Cell RepCD103 Expression Is Not Required for Maintenance or
Localization of CD8s within the Salivary Gland
It has been suggested that expression of CD103 is important
for enforcing the residency of lymphocytes in mucosal organs
by tethering T cells to the epithelium (Casey et al., 2012; El-
Asady et al., 2005). However, recent work has challenged
this notion for TRM cells within the si-IEL fraction (Sheridan
et al., 2014). For MCMV-driven OT-Is in the salivary gland,
CD103 expression was significantly correlated with epithelial
localization as assessed by proportion or by distance from
the epithelium (Figures 2A and S3B). Surprisingly, however,
CD103/ OT-I localization was comparable to wild-typeorts 13, 1137–1148, November 10, 2015 ª2015 The Authors 1139
(WT) OT-Is within the salivary gland (Figures 2A, 2B, S3A, and
S3B). These data suggest that CD103 expression marks IELs
in the salivary gland but is not essential for the IEL localization.
To determine whether CD103 is required for the maintenance
of MCMV-specific TRM in the salivary gland, we mixed con-
genically marked WT and CD103/ OT-Is before transfer
and MCMV-OVA infection. Although both populations had
reached the salivary gland and small intestine in large
numbers after 1 week, the CD103/ OT-Is were slightly un-
derrepresented in the salivary gland and the si-IEL relative to
the spleen (Figure 2C). In the salivary gland, the ratio of
CD103/ to WT OT-Is was maintained stably over several
weeks and only slightly favored WT OT-Is even after 22 weeks
(Figure 2D). Importantly, the numbers of CD103/ OT-Is did
not decline over time (Figure S4A). Rather, this shift in ratio re-
flects a slight increase in the numbers of WT OT-Is in the sali-
vary gland (Figure S4A). This subtle preferential maintenance
of WT OT-Is was more pronounced in the si-IEL over time
and unexpectedly, in the spleens of the same mice (Figure 2D),
reflecting a greater loss of CD103/ cells after day 7 (Figures
S4B and S4C). The CD103/ OT-Is in the salivary gland and
si-IEL expressed high levels of CD69 from week 2 onward,
mirroring the WT OT-Is in the same mice (Figures 2E, 2F,
S4D, and S4E). These data suggest that CD103/ OT-Is
had a defect in their initial migration to the salivary gland but
were maintained stably thereafter. To test whether persistent
antigen was masking a defect in the maintenance of
CD103/ OT-Is, we isolated activated WT and CD103/
OT-Is from the spleen of adoptive transfer recipients 1 week
after infection and transferred equal numbers into naive
mice. Both OT-I populations migrated to the salivary gland
and upregulated markers of residency (Figure 2G). Again,
CD103/ OT-Is were underrepresented in the salivary
gland 2 weeks after transfer, but the proportion of WT and
CD103/ OT-Is was unchanged over the next 3 weeks, indi-
cating that both WT and CD103/ OT-Is were maintained
similarly in the salivary gland, even in the absence of antigen
(Figure 2H). Thus, whereas CD103 marks TRM cells with an
IEL localization in the salivary gland, it is not required for their
formation, localization, or maintenance.
MCMV-Specific CD8s that Undergo Memory Inflation
AreMaintained at Higher Numbers thanNon-inflationary
CD8s in the Salivary Gland
Within the endogenous CD8+ T cell populations, cells respond-
ing to different MCMV epitopes display different kinetics of accu-
mulation or contraction. Inflationary populations (represented by
M38- and IE3-specific CD8s in B6 mice) are maintained at high
levels in the blood by ongoing antigen stimulation, whereas
non-inflating populations (represented by M45- and M57-spe-
cific CD8s) undergo substantial contraction after the acute
phase of infection, likely because their antigen becomes unavai-
lable (Dekhtiarenko et al., 2013), and are maintained homeostati-
cally (Figures S5A–S5D; Smith et al., 2014; Snyder et al., 2008).
Because TRM cells do not rely on antigen (Casey et al., 2012;
Mackay et al., 2012), we did not expect these kinetics to be
reflected in the TRM populations. We sacrificed cohorts of B6
mice infected with WT-MCMV (strain K181) at different times1140 Cell Reports 13, 1137–1148, November 10, 2015 ª2015 The Aupostinfection. Inflationary M38- and IE3-specific CD8s were pre-
sent in the salivary gland within 1–3 weeks of infection and were
maintained stably once they’d reached their peak levels (Figures
3A and 3B), mirroring their kinetics in the spleen (Figures S5A and
S5B). Surprisingly, non-inflationary populations in the salivary
gland declined significantly in a prolonged manner over at least
10weeks (Figures 3C and 3D). Whereas this contrasts to the dra-
matic contraction that occurred in the spleens of the same mice
(Figures S5C and S5D), non-inflationary T cells had become
subdominant to inflationary cells by late times after infection (Fig-
ures 3E and 3F). The change in immunodominance was not
associated with any major differences in expression of CD69
or CD103 between populations (Figure S5E). Nevertheless, infla-
tionary T cells were far more prevalent in the blood and thus it
was possible that these cells were circulating passively through
the salivary gland and driving the shift in immunodominance. To
test this, we injected CFSE i.v. into latently infected mice, which
labeled the vast majority of inflationary cells in the blood, with
minimal labeling of T cells in the salivary gland (Figure 3G). Sev-
enty-four days later, CFSE-labeled T cells had not equilibrated in
the salivary gland (Figure 3H). Even though migrating cells could
lose CFSE by dividing upon salivary gland entry, these data sug-
gest that the shift in immunodominance is not caused by infla-
tionary cells passively circulating through the salivary gland at
steady state.
MCMV-Specific TRM in the Salivary GlandDoNot Depend
on Viral Replication
Circulating inflationary T cells quickly become immune domi-
nant because they undergo prolonged antigen-driven division
(Torti et al., 2011; Figures S6B–S6E). Unlike other organs, the
salivary gland harbors replicating virus for prolonged periods
of time. In our hands, MCMV transcripts encoding the late
gene glycoprotein B (gB) were evident in the salivary gland for
at least 10 weeks after infection (Figure 4A). The disappearance
of gB transcripts correlated with the loss of non-inflationary
T cells from the salivary gland (Figures 3C and 3D). Thus, it
was possible that the presence of antigen promoted the prolif-
eration of TRM cells in the salivary gland. To test whether viral
replication in the salivary gland affects the rate of TRM division,
we compared WT-MCMV to a spread defective version of
MCMV that lacks the essential glycoprotein L (DgL-MCMV).
This virus is a single-cycle virus in vivo that cannot spread but
still induced memory inflation (Snyder et al., 2011) and TRM
phenotype cells inmultiplemucosal tissues after an i.p. infection
(Figure S6A). Any TRM division driven by replicating virus in the
salivary gland should be absent from mice infected with DgL-
MCMV. However, there was no difference in salivary gland
T cell division (assessed by KI-67 expression) between mice
infected withWT- andDgL-MCMV beyond 1 week postinfection
(Figures 4B–4E). We also adoptively transferred activated OT-Is
into these mice on day 5 of infection. Because neither virus ex-
presses OVA, these OT-Is serve as a reference population for
antigen-independent division. Remarkably, OT-Is recovered
from these salivary glands expressed KI-67 at an identical rate
as endogenous T cells despite the complete absence of the
OVA antigen (Figures 4B and 4C). Collectively, these data sug-
gest that neither viral replication nor antigen in the salivary glandthors
Figure 3. Inflationary CD8s Are Preferen-
tially Maintained in the Salivary Gland dur-
ing the Latent Stages of Infection
(A–D) B6 cohorts were infected with K181 MCMV
and sacrificed at indicated times postinfection.
Absolute numbers of CD8s in salivary gland spe-
cific for inflationary epitopes M38 (A) and IE3 (B)
and non-inflationary epitopes M45 (C) andM57 (D)
are shown. Dotted lines indicate average number
of cells at week 1 for comparison. Asterisks indi-
cate significant differences from week 1 (see also
Figure S5).
(E and F) Ratio of M38-specific to M45-specific
cells (E) or IE3-specific to M57-specific cells (F) in
the salivary gland and spleen of each mouse
calculated from the numbers shown in (A)–(D).
Dotted lines indicate a ratio of 1. Data are
combined from seven independent experiments
(n = 4–16 mice per time point).
(G) FACS plots of blood and salivary gland from
latently infectedmice 45min after i.v. injection with
CFSE.
(H) Latently infected mice were given three i.v.
injections of CFSE over 1 week and sacrificed
74 days later. Shown is the frequency of CFSE on
inflationary and non-inflationary cells in spleen and
salivary gland. Results are combined from two
independent experiments (n = 6).
Error bars represent the SEM. Statistical signifi-
cance was measured by unpaired (A–D) and
paired (H) Student’s t tests (*p < 0.05; **p < 0.01;
***p < 0.001; ****p < 0.0001).accounts for the preferential maintenance of TRM cells with infla-
tionary specificities. Thus, we hypothesized that a continuous
antigen-driven influx of inflationary T cells during latency might
explain these data.
Levels of TGF-b in the Salivary Gland Are Not Markedly
Altered by MCMV Infection or Latency
To investigate TRM formation at late times postinfection, we first
wanted to determine how viral replication and latency in the sali-
vary gland influences the expression of TGF-b, IL-33, and TNF-a,
which are critical for TRM differentiation (Casey et al., 2012; El-
Asady et al., 2005; Graham et al., 2014; Mackay et al., 2013;
Sheridan et al., 2014). Indeed, MCMV-stimulated T cells upregu-
lated CD103 in response to TGF-b and upregulated CD69 in
response to IL-33 and TNF-a (Figures 5A and 5B), consistentCell Reports 13, 1137–1148, Nowith previous work (Casey et al., 2012;
Skon et al., 2013). Transcripts encoding
TGF-b, IL-33, and TNF-a were slightly
increased at day 7 of infection with
WT-MCMV (Figure 5C). However, levels
of these cytokines were not markedly
altered after day 7, even at late times,
and the increased transcription of TGF-b
did not correspond to higher levels of to-
tal or active TGF-b in the gland as a whole
(Figures 5D and 5E). Infection with
DgL-MCMV did not similarly increaseTGF-b transcription (Figure 5F). These data suggest that
MCMV replication and latency in the salivary gland have a mini-
mal impact on the availability of cytokines responsible for
inducing TRM cells. Thus, if MCMV-specific cells were to arrive
in the salivary gland at late times after infection, the available
levels of cytokine and antigen are unlikely to be a limiting factor
in their ability to form new TRM cells.
Inflationary Cells from the Spleen Can Become TRM with
Reduced Efficiency
Memory inflation promotes the accumulation of T cells with an
effector phenotype. To determine whether inflationary cells retain
the capacity to become TRM, wemixed naive OT-Is with inflation-
ary OT-Is from the spleens of latently infected mice and co-trans-
ferred these cells into naive recipients. Infecting these mice withvember 10, 2015 ª2015 The Authors 1141
Figure 4. Viral Replication in the Salivary
Gland Does Not Drive Replication of
MCMV-Specific TRM
(A) Nested RT-PCR for MCMV gB performed on
cDNA (top) or total DNA (bottom) extracted from
salivary glands of mice infected with wild-type
MCMV. Each lane represents an individual mouse.
Lanes labeled H2O contained no template. All
samples were positive in a PCR reaction for
b-actin, and all reverse-transcriptase-negative
cDNA samples were negative for gB (not shown).
(B–E) Mice were infected with wild-type MCMV
or DgL-MCMV. At 5 days postinfection, mice
received transfer of OT-Is sorted from spleens of
mice infected for 5 days with MCMV-OVA. Shown
is the frequency of KI-67 among endogenous
antigen-specific CD8s and donor OT-Is in the
salivary gland at day 7 (B), day 14 (C), day 35 (D), or
at latent times (E).
See also Figure S6. Error bars represent the SEM.
Statistical significance was measured by unpaired
Student’s t tests (*p < 0.05; **p < 0.01; ***p <
0.001).MCMV-OVA markedly expanded OT-Is from both donors and
drove large numbers into the non-lymphoid tissues (Figure 6A).
However, even though restimulated and primary OT-Is were
approximately equal in the blood, restimulated OT-Is were under-
represented in the parenchyma of all organs tested andmarkedly
so in both the salivary gland and si-IEL (Figure 6B). Importantly,
similar results were obtained when naive and latent OT-Is were
transferred into separatemice and challenged, ruling out the pos-
sibility that competition or an altered environment were affecting
the results (not shown). In all cases, restimulated T cells were
significantly less likely to express CD69 and CD103 compared
to cells undergoing a primary infection (Figure 6C) consistent
with previouswork (Masopust et al., 2006). Indeed,when restimu-
lated inflationary cells were treated with cytokines in vitro, they
were less able to express CD103 in response to TGF-b compared
toCD8s froman acute infection (Figure 6D compare to Figure 5A).
Together, these data show that inflationary T cells from late times
after infection can migrate to mucosal tissues and differentiate
into TRM upon restimulation but do so less efficiently than cells un-
dergoing a primary response to infection.
Circulating Inflationary CD8s Traffic to and Become
Resident in the Salivary Gland during Latent Infection
Inflationary cells were clearly able to respond to a new infection
by becoming TRM in the salivary gland. To assess the level at1142 Cell Reports 13, 1137–1148, November 10, 2015 ª2015 The Authorswhich this occurred in the absence of an-
tigen, inflationary OT-Is were harvested
from the spleen 1 week or >12 weeks af-
ter infection. These cells were transferred
into naive mice to assess their migration
to the salivary gland. Transferred OT-Is
from latently infected mice infiltrated the
salivary glands at a lower rate than
OT-Is from 1 week postinfection (Figures
7A, 7B, and S7A). Regardless of thedonor, KLRG1+ cells failed to traffic to the salivary gland entirely
(Figures 7A and 7B). Interestingly, TRM phenotype cells were rare
and almost completely absent when cells were derived from
latently infected mice (Figure 7B). These data show that
MCMV-specific T cells in the spleen during latency can migrate
into the salivary gland at a low level irrespective of viral antigen
or infection but that TRM differentiation is rare without recent
exposure to antigen.
To determine whether latent infection with MCMV increased
the recruitment or TRM differentiation of inflationary cells, we
transferred CFSE-labeled OT-Is from the spleens of latently in-
fected mice into mice latently infected with MCMV-OVA (with
antigen) or WT-MCMV (lacking antigen). As above, KLRG1+
OT-Is failed to access the salivary gland in all cases (Fig-
ure S7B). Comparing the number of donor OT-Is in the salivary
gland to the spleens of the same mice normalized the results
for variations in transfer efficiency or the impact of antigen-
driven expansion. The presence of the OVA antigen slightly
improved the rate of recruitment of OT-I T cells to the salivary
gland over that of naive or WT infected mice (Figure 7C).
However, OT-Is that made it to the salivary gland in MCMV-
OVA-infected recipients were significantly more likely to have
upregulated CD69 and CD103, although expression of both
molecules was variable and reduced compared to OT-Is driven
by a primary infection (Figures 7D and 7E). Moreover, OT-Is
Figure 5. MCMV in the Salivary Gland Does
Not Alter Cytokines Important for TRM Dif-
ferentiation
(A and B) Splenocytes isolated 4 days after infec-
tion with K181 MCMV were treated in vitro with
TGF-b, TNF-a, and IL-33 alone or in combination
for 40 hr (n = 9). Shown is the frequency of CD103
(A) and CD69 (B) on CD8s. Dotted lines indicate
marker expression without cytokines.
(C) Transcription in salivary gland of the indicated
cytokines normalized to GAPDH determined by
qRT-PCR after infection with WT MCMV. Data
shown are the average for one to four replicates
per sample (n = 3 or 4 mice per group).
(D and E) Protein levels of total (D) and active (E)
TGF-b determined by ELISA (n = 3 or 4 mice per
group).
(F) Transcription of TGF-b in salivary gland 1 week
after infection with WT MCMV or DgL-MCMV.
Data shown are the average for one or two repli-
cates per sample (n = 2–4 mice per group).
Error bars represent the SEM. Statistical signifi-
cancewasmeasured by unpaired Student’s t tests
(*p < 0.05; **p < 0.01; ***p < 0.001).that reached the salivary gland in MCMV-OVA-infected recipi-
ents were enriched for cells that had fully diluted their CFSE
(Figure S7C), and CD103-expressing OT-Is were exclusively
CFSE low (Figure 7F, left), which is indicative of antigen-driven
division. Interestingly, CD69 expression did not show a similar
restriction and was expressed on both divided and undivided
OT-Is in the salivary gland (Figure 7F, right). These data are
consistent with the idea that antigen promotes TRM differentia-
tion during latency. To directly test the hypothesis that antigen
stimulation outside of the salivary gland is sufficient to drive
inflationary cells to become TRM, we isolated spleens with infla-
tionary OT-Is from latently infected mice, stimulated the T cells
with SIINFEKL peptide in vitro, and adoptively transferred these
cells into naive mice. OT-Is that had been stimulated with pep-
tide reached the salivary gland in significantly greater numbers
and upregulated TRM markers more efficiently than unstimu-
lated OT-Is, even in the absence of any inflammation or antigen
in the recipient (Figures 7G, 7H, and S7D). Together, these
data show that MCMV-specific T cells in the spleen during
latency could migrate to the salivary gland with or without
antigen at steady state but that the establishment of a TRM
phenotype was antigen dependent. Furthermore, antigen
recognition outside of the salivary gland was sufficient to pro-Cell Reports 13, 1137–1148, Nomote new TRM formation and supple-
ment established TRM populations.
To estimate the recruitment of infla-
tionary T cells at steady state, we used
the numbers of salivary-gland-localized
donor cells measured after transfer of in-
flationary OT-Is into recipients latently
infected with MCMV-OVA (Figure 7C).
This analysis suggests that, for every
1,000 OT-Is in the spleen, 8.6 (±2.3
SEM) OT-Is were recruited to the salivarygland over a 30-day period. Whereas this seems like a small
number, it is important to note that, as a result of memory infla-
tion, the average latently infected mouse contains 256,183
(±21,770) OT-Is in the spleen. Given these numbers, we would
expect approximately 2,195 (±494.1) OT-Is to be recruited to
the salivary gland over the course of 30 days, which would
represent 5.5% (±1.47%) of the OT-Is in an average salivary
gland. Given the variable expression of TRM markers on trans-
ferred OT-Is (Figures 7D and 7E), we would not expect all of
these cells to develop into new TRM cells. Nevertheless, this
represents a substantial pool from which new TRM can be
generated. Inflationary T cells are present at much higher
numbers than non-inflationary populations during latent infec-
tion, precisely because they respond to viral antigen during
this phase (Seckert et al., 2011; Torti et al., 2011). Thus, recruit-
ment of inflationary populations would be heavily favored over
non-inflating CD8s, which is consistent with the different main-
tenance of inflators and non-inflators in the salivary gland
(Figure 3). Collectively, our data indicate that MCMV infections
robustly induce intraepithelial TRM populations independently of
viral replication in the mucosa and, surprisingly, that these TRM
populations can be dynamically supported by continuous TRM
formation from the circulating pool.vember 10, 2015 ª2015 The Authors 1143
Figure 6. Inflationary CD8s Have a Reduced
Capacity to Become TRM after a New Infec-
tion
CD45.1+ inflationary OT-Is from the spleen
>12 weeks after infection and CD45.1+/CD45.2+
naive OT-Is were mixed and transferred into naive
B6 recipients (CD45.2+), which were then chal-
lenged with MCMV-OVA.
(A) FACS plots show frequency of OT-Is (left) and
expression of CD69 and CD103 on restimulated
OT-Is (middle) or OT-Is undergoing a primary
response (right), in blood, spleen, or i.v. unlabeled
fraction of the indicated organs 2 weeks after
challenge.
(B) Ratio of restimulated to primary OT-Is in i.v.
unlabeled fraction of the indicated organs.
(C) Frequency of CD103 and CD69 co-expression
on restimulated and primary OT-Is in i.v. unlabeled
fraction of the indicated organs. Each line con-
nects populations in an individual mouse. Data are
representative of two experiments (n = 5).
(D) Expression of CD103 on restimulated infla-
tionary CD8s after treatment with cytokines as in
Figure 5A (n = 3). Dotted line indicates CD103
expression without cytokines.
Error bars represent the SEM. Statistical signifi-
cance was measured by paired Student’s t tests
(*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001).DISCUSSION
CMV has drawn much interest as a vaccine vector due to its
unique ability to induce antigen-driven memory inflation. Most
notably, work using Rhesus CMV (RhCMV) as a vaccine vector
for simian immunodeficiency virus (SIV) has led to remarkable
protection of the vaccinated animals (Hansen et al., 2009,
2011, 2013). These authors have speculated that CMV-based
vaccines may be so effective because they can sustain large
numbers of T cells at the mucosal sites of SIV (and HIV)
entry (Masopust and Picker, 2012). Indeed, such TRM cells are
emerging as critical players in the surveillance of barrier tissues.
Using the MCMVmodel, we have recently shown that most cells
undergoing memory inflation are confined to the circulation and
are not found within the parenchyma of mucosal or non-mucosal1144 Cell Reports 13, 1137–1148, November 10, 2015 ª2015 The Authorstissues (Smith et al., 2014). In this manu-
script, we show that MCMV infection
induces the early formation of TRM cells
that broadly distribute through the
mucosal tissues of the body. Moreover,
we found that a single-cycle spread-
defective version of MCMV, which could
be a useful platform on which to base a
vaccine, also induced TRM cells to form
in multiple mucosal sites (Figure S6).
Most surprisingly, we found that MCMV-
driven TRM populations can be dynami-
cally supported by the recruitment of
circulating T cells (Figure 7), which heavily
favors the inflationary T cells. It is likely
that most of these late-arriving T cellsfail to differentiate into TRM cells (Figures 7D and 7E). Indeed,
previous work showed that T cells entering mucosal tissues
from the circulation did not upregulate CD69 to the degree of
cells already resident in the mucosa (Skon et al., 2013). Never-
theless, restimulation of splenic inflationary T cells could clearly
drive the formation of new TRM cells, albeit inefficiently, even in
latently infected or naive mice (Figures 6 and 7). Thus, the large
numbers of T cells stimulated by CMV-based vectors may be
uniquely able to promote and sustain TRM cells in multiple
mucosal tissues.
The role of sustained local antigen in the formation and main-
tenance of TRM cells is unclear. This is noteworthy because CMV
persists in many sites throughout the body. Antigen is not
needed for the formation of TRM in the skin or small intestine after
T cell priming (Casey et al., 2012; Mackay et al., 2012) and
Figure 7. Inflationary CD8s Can Become
TRM in the Salivary Gland during Latent
Infection
OT-Is were isolated from the spleens of mice at
1 week or >12 weeks after MCMV-OVA infection
and transferred into congenic naive mice.
(A) FACS plots of donor OT-Is (left) and their
expression of KLRG1 (right) in the spleen of re-
cipients 2 weeks posttransfer.
(B) Donor OT-Is (left) and their expression of
KLRG1 (middle) or CD69 and CD103 (right) in the
salivary gland of recipients 2 weeks posttransfer.
(C–F) Mice latently infected with MCMV-OVA or
MCMV-WT received CFSE-labeled OT-Is from
spleens of mice >12 weeks postinfection with
MCMV-OVA. (C) Ratio of the number of OT-Is in
the salivary gland to the spleen of the samemouse
2–4 weeks after transfer into the indicated re-
cipients is shown. Frequency of CD69 (D) and
CD103 (E) on transferred OT-I in the parenchyma
of the salivary gland compared to OT-Is in the
salivary gland 4 weeks after primary infection
(primary) is shown. (F) FACS plots of CFSE and
CD103 or CD69 on OT-I donors in the salivary
glands of latently infected MCMV-OVA recipients.
Each plot shows an individual mouse.
(G and H) OT-Is from spleens of latently infected
mice were harvested and stimulated with
SIINFEKL in vitro for 3 hr before transfer into
naive recipients. (G) Absolute numbers of OT-Is in
spleen and salivary gland of naive recipients
2 weeks posttransfer are shown. (H) FACS plots of
CD103 and CD69 on transferred OT-Is 2 weeks
posttransfer are shown.
See also Figure S7. Error bars represent the SEM.
Statistical significance was measured by unpaired
Student’s t tests (*p < 0.05; **p < 0.01; ***p < 0.001;
****p < 0.0001).persistent antigen may antagonize TRM in the small intestine
(Casey et al., 2012), although chronic LCMV clone 13 infection
may also promote sustained T cell migration to the small intes-
tine (Zhang and Bevan, 2013). In contrast, sustained antigen
has been proposed to bolster TRM formation in the lung after
influenza infection (Lee et al., 2011). Thus, the impact of persis-
tent antigen on TRM formation may vary by the infection or tissue.
CMV infects and replicates for prolonged periods of time in the
salivary gland and uses this mucosal barrier tissue as a primary
means of transmission, along with breast milk, urine, and vaginal
secretions (Crough and Khanna, 2009; Krmpotic et al., 2003; Ku-
mar et al., 1984; Wu et al., 2011). We identified MCMV-driven
TRM in all of these sites to varying degrees. However, spread-Cell Reports 13, 1137–1148, Nodefective DgL-MCMV clearly induced a
similar pattern of TRM formation, ruling
out a direct role for viral replication in
the formation of MCMV-specific mucosal
TRM cells. Moreover, we could find no ev-
idence that viral antigen in the salivary
gland resulted in any increase in the rate
of T cell division within the salivary gland
(Figure 4). Indeed, viral immune evasiongenes are thought to markedly restrict CD8+ T cell recognition
of infected cells in the salivary gland (Walton et al., 2011). More-
over, a low dose of LCMV-WE, which does not lead to salivary
gland infection, also promoted TRM cells in this site (Thom
et al., 2015 in this issue of Cell Reports). Nevertheless, the pres-
ence of antigen in latently infected mice may have caused a
slight improvement in the rate of recruitment of inflationary cells
to the salivary gland (Figure 7C) and clearly enhanced TRM differ-
entiation (Figures 7D and 7E). We have previously demonstrated
that circulating MCMV-specific T cells undergo a constant low
level of antigen stimulation primarily at sites that are accessible
to the blood, such as the spleen or liver, where the virus is known
to persist (Smith et al., 2014). It is clear that restimulated T cellsvember 10, 2015 ª2015 The Authors 1145
can traffic to the salivary gland and form new TRM (Figures 6
and 7; Hofmann and Pircher, 2011), even when they were stim-
ulated prior to infiltration of the salivary gland (Figures 7E–7G).
Thus, we favor themodel that, at late times after infection, the re-
stimulation of blood-localized cells drives memory inflation and
also promotes the continuous migration of T cells to the mucosa
and formation of TRM.
Recent work has indicated that responsiveness to TGF-b is a
general requirement for the development of TRM cells in multiple
sites (Casey et al., 2012; El-Asady et al., 2005; Lee et al., 2011;
Mackay et al., 2013; Sheridan et al., 2014; Skon et al., 2013;
Zhang and Bevan, 2013), and it is thought that these TGF-b
signals are received within the target tissue. TGF-b signals
are particularly important for expression of CD103 on T cells,
including MCMV-driven T cells (Figure 5; Thom et. al., 2015),
which is thought to promote the retention of TRM cells within
the epithelium of the gut and lungs and the epidermis of the
skin (Casey et al., 2012; El-Asady et al., 2005; Lee et al., 2011;
Mackay et al., 2013; Zhang and Bevan, 2013). However, after
an oral Listeria monocytogenes infection, CD103-deficient
T cells were recruited poorly into the si-IEL but were maintained
comparably to WT T cells (Sheridan et al., 2014). In agreement
with this, our data suggest that CD103 expression correlates
with the epithelial localization of MCMV-driven T cells in the sali-
vary gland (Figure 2A) but that the absence of CD103 does not
impair the localization or maintenance of TRM after MCMV infec-
tion, even in the absence of viral antigen (Figures 2, S3, and S4).
Collectively, our data show that MCMV infection robustly in-
duces mucosal TRM cells. In the salivary gland, these cells adopt
an intraepithelial localization and persist in large numbers, in part
as a result of continual recruitment from the circulating T cell
pool and antigen-driven differentiation. These data show that
mucosal TRM cells stimulated by a ubiquitous persistent infection
can be maintained dynamically and support the use of CMV-
based vaccine vectors to promote long-term mucosal immunity.
EXPERIMENTAL PROCEDURES
Mice and Infections
All mice were purchased from Jackson Laboratory and bred in house.
C57BL/6 (B6) mice were used for all direct infections, and B6 or CD45.1 con-
genic mice (B6.SJL-Ptprca Pepcb/BoyJ) were used as recipients for adoptive
transfer experiments. OT-Is on a B6 background (C57BL/6-Tg(TcraTcrb)
1100Mjb/J) were bred to CD45.1 congenic mice (B6.SJL-Ptprca Pepcb/
BoyJ) or CD103/ mice (B6.129S2(C)-Itgaetm1Cmp/J) to generate congenic
or CD103/ OT-Is. Inflationary OT-Is were generated as described (Turula
et al., 2013). For mixed WT and CD103/ OT-I transfers, 1,000 splenocytes
from each donor were transferred into naive mice, which were infected with
MCMV-OVA 1 day later. Transfers from latently infected mice were performed
as in Smith et al. (2014). For in vitro stimulation of OT-Is, splenocytes were
harvested from latently infected mice harboring OT-Is and were incubated
for 3 hr at 37C at a concentration of 1 3 107 splenocytes/ml with either
1 mg/ml SIINFEKL or without peptide before transfer. MCMV K181 (WT-
MCMV), MCMV K181-tfr-OVA (MCMV-OVA), and MCMV-DgL were produced
as described (Snyder et al., 2008; Zurbach et al., 2014). In all cases, mice were
infected i.p. with 2 3 105 pfu of virus. All protocols were approved by the
Thomas Jefferson University Institutional Animal Care and Use Committee.
Lymphocyte Isolation and FACS Staining
Lymphocytes from the blood, spleen, liver, salivary glands, mammary glands,
kidneys, and female reproductive tracts were isolated as described (Smith1146 Cell Reports 13, 1137–1148, November 10, 2015 ª2015 The Auet al., 2014). Lymphocytes from the small intestine IEL and lamina propria
were isolated using the previously described protocol (Lefranc¸ois and Lycke,
2001). Intravascular staining was performed as described recently (Smith
et al., 2014). Antigen-specific non-transgenic CD8s were identified with tetra-
mers produced at the NIH tetramer core facility (http://tetramer.yerkes.emory.
edu/) as previously described (Snyder et al., 2008). Analyses of cellular pheno-
type and donor cells in adoptive transfers were performed as described previ-
ously (Smith et al., 2014) with the additions of antibodies specific for CD103
(clone 2E7) and CD69 (clone H1.2F3). All antibodies were purchased from Bio-
legend or BD Biosciences. Cells were analyzed on an LSR II flow cytometer
(BD Biosciences) and using FlowJo software (TreeStar).
In Vivo Labeling
For the long-term BrdU pulse (Figure 1), mice were injected i.p. with 1 mg of
BrdU (Sigma) on the day of infection and then subsequently provided with
0.8 mg/ml BrdU in their drinking water for the next 9 weeks. BrdU labeling
was assayed using the BD Biosciences Flow kit. In vivo CFSE labeling was
adapted from previous work (Becker et al., 2004). For the long-term pulse/
chase, 45 mg of CFSE/mouse was injected retro-orbitally every other day for
a total of three injections.
Immunofluorescent Microscopy
Sections of salivary glands were processed as described previously (Smith
et al., 2014) and stained with antibodies against CD45.2 (clone 104),
E-cadherin (clone DECMA-1), and CD103 (clone 2E7) and co-stained with
DAPI (Prolong Gold antifade; Life Technologies). All antibodies were pur-
chased from Biolegend. Images were generated with the LSM 510 Meta
(Carl Zeiss) confocal laser scanning microscope and the LSM image browser
software (Carl Zeiss) and analyzed with Fiji software (Schindelin et al., 2012).
PCR and ELISA
RNA was isolated from salivary glands with RNeasy Mini kit (QIAGEN), and
cDNA was generated with the High Capacity cDNA Reverse Transcriptase
kit (Applied Biosystems). DNA was isolated using the Gentra Puregene Tissue
kit (QIAGEN). Nested PCR for gB transcripts and latent gBDNAwas performed
as described (Cook et al., 2002). Transcript levels of TNF-a, TGF-b, and IL-33
were assessed by qPCR with a StepOnePlus system (Applied Biosystems)
using SYBR green (Applied Biosystems) for detection. Primers are listed in
Supplemental Information. Protein levels of active and total TGF-bwere deter-
mined using Legend MAX ELISA kits (Biolegend).
In Vitro Cytokine Assay
Naive mice (Figures 5A and 5B) or naive mice that received an adoptive transfer
of CD8s from latently infectedmice (Figure 6D) were infectedwithMCMV-K181.
Four days later, splenocyteswere isolated and cultured for 40 hr in the presence
of cytokines as described (Casey et al., 2012) and analyzed by FACS.
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